Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lighthouse Tech awarded CHF 1.2M from Innosuisse, and launches Equity Crowdfunding round to scale growth
-
Campaign to allow 16-year-olds to open ISAs wins overwhelming support from public and leading finance influencers
-
Zhuanghe strawberries from Liaoning, China hit the market early
-
Notice of Extraordinary General Meeting in Karolinska Development AB (publ)
-
Form 8.5 (EPT/RI)-NCC Group plc
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Goliath Reports 10 High-Grade Holes Up To 7.28 g/t Au Over 8.00 Meters Within 5.85 g/t Au Over 10.00 Meters In RIRG Dyke (417m - 427m downhole and 500m Above Valley Floor) At The 1.8 Km2 Surebet Disco
-
Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth
-
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
-
New Data Show Tesla in Danger of Losing Its Way as European Consideration to Buy Chinese Cars Jumps 16% in 12 Months
-
tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH
-
Heating, injury and health greatest winter concerns for UK families with older loved ones, Elder data reveals
-
Secured Crypto Casino USA 2025: Jackbit Bitcoin Casino Recognized for 30% Rakeback and No-KYC
-
Viridien: Information on the total number of voting rights and shares
-
Orbus Software Names Steve Fulton as Chief Executive Officer
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Joveo Unveils AI Staffing Advisor: The Industry’s First Staffing Superintelligence Platform
-
ING Selects VMware Cloud Foundation 9.0 as Strategic Platform for Private Cloud Modernization
-
Mutuum Finance (MUTM) Nears Full Presale Allocation as Phase 6 Reaches 98% With Over 18,000 Investors
-
BuySellVouchers Launches Holiday Sale: Save Up to 30% When Buying Gift Cards With Crypto
-
Vandria Reports Positive Phase 1 Target Engagement Data for VNA-318, Supporting Further Development in Alzheimer’s Disease
-
The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki
-
Municipality Finance issues EUR 100 million notes under its MTN programme
-
Eesti Energia subsidiary, Enefit Green, divests Tolpanvaara Wind Farm in Finland
-
Virtune informs about an update by reference price provider MarketVector regarding the underlying price source for single-asset ETPs
-
CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia
-
Bitget Supports Grassroots Football at LALIGA Youth Tournament in Manila
-
Extension of the powers of a member of the Management Board of OÜ TS Laevad – a subsidiary of AS Tallinna Sadam
-
Capgemini develops agentic AI solution to support UNICEF in improving youth access to green careers
-
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
-
ASML reports transactions under its current share buyback program
-
DIRECTOR / PDMR NOTIFICATION
-
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
-
FTMO Building Global Trading Powerhouse – Completes Acquisition of OANDA from CVC
-
Issue of Equity and Total Voting Rights
-
Endeavour Targets Discovery of 12-15 Million Ounces of Resources Over The Next 5 Years
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
Offer Update
-
Progress on share buyback programme
-
Equinor ASA: Share buy-back – fourth tranche for 2025
-
Statkraft and Hunton Fiber enter into new, eight-year power agreement
-
Aktsiaselts Infortar Reporting Calendar 2026
-
Elis: Disclosure of trading in own shares occured from November 25 to November 26, 2025
-
Sonesta International Hotels Implements Industry-Leading Cloud Security Through AccuKnox Collaboration
-
Toobit Expands Trading Tools Suite with Altrady Integration
-
Sampo plc’s share buybacks 1 December 2025
-
Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA
-
Start of Day Message
-
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion

